Skip to main content
Industry News
Pfizer, BioNTech launch COVID-19 vaccine trial for kids

Pfizer and BioNTech said on Thursday that they have begun evaluating their COVID-19 vaccine in children ages 6 months to 11 years both in the US and Europe. The trial will enroll an estimated 4,644 children and results could be available by the second half of this year.

Full Story: